Intech Investment Management LLC Sells 53,621 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Intech Investment Management LLC cut its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 52.6% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The firm owned 48,301 shares of the company’s stock after selling 53,621 shares during the period. Intech Investment Management LLC’s holdings in Henry Schein were worth $3,096,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. KBC Group NV lifted its holdings in Henry Schein by 163.5% in the fourth quarter. KBC Group NV now owns 521,964 shares of the company’s stock worth $39,518,000 after buying an additional 323,901 shares during the period. Everett Harris & Co. CA boosted its position in shares of Henry Schein by 13.9% during the first quarter. Everett Harris & Co. CA now owns 119,257 shares of the company’s stock valued at $9,006,000 after purchasing an additional 14,580 shares in the last quarter. UniSuper Management Pty Ltd grew its stake in Henry Schein by 611.8% in the first quarter. UniSuper Management Pty Ltd now owns 13,695 shares of the company’s stock worth $1,034,000 after purchasing an additional 11,771 shares during the period. Envestnet Portfolio Solutions Inc. raised its holdings in Henry Schein by 64.2% in the first quarter. Envestnet Portfolio Solutions Inc. now owns 41,558 shares of the company’s stock worth $3,138,000 after purchasing an additional 16,241 shares in the last quarter. Finally, Artisan Partners Limited Partnership raised its holdings in Henry Schein by 9.5% in the fourth quarter. Artisan Partners Limited Partnership now owns 292,911 shares of the company’s stock worth $22,176,000 after purchasing an additional 25,378 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Down 1.9 %

HSIC stock opened at $71.15 on Monday. Henry Schein, Inc. has a 1-year low of $60.01 and a 1-year high of $82.63. The business has a fifty day moving average price of $69.89 and a 200-day moving average price of $70.31. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.55 and a quick ratio of 0.90. The stock has a market capitalization of $9.11 billion, a P/E ratio of 24.04, a P/E/G ratio of 1.88 and a beta of 0.86.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, beating the consensus estimate of $1.22 by $0.01. The firm had revenue of $3.10 billion during the quarter, compared to analysts’ expectations of $3.27 billion. Henry Schein had a net margin of 2.82% and a return on equity of 13.19%. The firm’s quarterly revenue was up .0% on a year-over-year basis. During the same period in the previous year, the company earned $1.31 earnings per share. Equities analysts forecast that Henry Schein, Inc. will post 4.75 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of analysts have recently weighed in on the stock. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. UBS Group decreased their target price on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating for the company in a research note on Wednesday, August 7th. JPMorgan Chase & Co. dropped their price target on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. Piper Sandler reaffirmed an “overweight” rating and set a $86.00 price objective on shares of Henry Schein in a research report on Friday, June 21st. Finally, Evercore ISI lowered their price objective on Henry Schein from $72.00 to $70.00 and set an “in-line” rating for the company in a research note on Wednesday, August 7th. One investment analyst has rated the stock with a sell rating, six have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $77.10.

Insider Activity

In related news, SVP Lorelei Mcglynn sold 21,035 shares of Henry Schein stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company’s stock, valued at $4,978,026.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.